613 related articles for article (PubMed ID: 8670865)
1. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
2. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
4. Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases.
Dowd S; Sneddon AA; Keyse SM
J Cell Sci; 1998 Nov; 111 ( Pt 22)():3389-99. PubMed ID: 9788880
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
6. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
7. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin.
Sánchez-Pérez I; Martínez-Gomariz M; Williams D; Keyse SM; Perona R
Oncogene; 2000 Oct; 19(45):5142-52. PubMed ID: 11064451
[TBL] [Abstract][Full Text] [Related]
8. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts.
Dorfman K; Carrasco D; Gruda M; Ryan C; Lira SA; Bravo R
Oncogene; 1996 Sep; 13(5):925-31. PubMed ID: 8806681
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M
Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359
[TBL] [Abstract][Full Text] [Related]
12. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.
Alessi DR; Smythe C; Keyse SM
Oncogene; 1993 Jul; 8(7):2015-20. PubMed ID: 8390041
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
[TBL] [Abstract][Full Text] [Related]
14. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
15. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
Loda M; Capodieci P; Mishra R; Yao H; Corless C; Grigioni W; Wang Y; Magi-Galluzzi C; Stork PJ
Am J Pathol; 1996 Nov; 149(5):1553-64. PubMed ID: 8909245
[TBL] [Abstract][Full Text] [Related]
16. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.
Brunet A; Roux D; Lenormand P; Dowd S; Keyse S; Pouysségur J
EMBO J; 1999 Feb; 18(3):664-74. PubMed ID: 9927426
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterisation of a uniquely regulated threonine, tyrosine phosphatase (TYP 1) which inactivates ERK2 and p54jnk.
King AG; Ozanne BW; Smythe C; Ashworth A
Oncogene; 1995 Dec; 11(12):2553-63. PubMed ID: 8545112
[TBL] [Abstract][Full Text] [Related]
19. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
20. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts.
Brondello JM; McKenzie FR; Sun H; Tonks NK; Pouysségur J
Oncogene; 1995 May; 10(10):1895-904. PubMed ID: 7761091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
